UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002887
Receipt number R000003523
Scientific Title A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy
Date of disclosure of the study information 2009/12/14
Last modified on 2017/12/20 09:53:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy

Acronym

LIPS study

Scientific Title

A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy

Scientific Title:Acronym

LIPS study

Region

Japan


Condition

Condition

IgA nephropathy

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study will examine inhibition of the progression of renal dysfunction in patients with dyslipidemia associated with IgA nephropathy in a group administered a combination of losartan and a statin and a group administered a statin alone.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The effectiveness of reducing proteinuria in spot urine samples will be compared in a control group receiving statin therapy alone for 2 years and a treatment group given statin therapy and losartan.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

statin and losartan group:
simvastatin 5mg and Losartan 50mg/day more than 3 months

Interventions/Control_2

statin group:
simvastatin 5mg/day more than 3 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Men and women over the age of 20
2.Patients with dislipidemia(LDL cholesterol: 120 mg/dL or higher)
3.Patients who need a therapy of hypertention (JSH2009)
4.Patients not taking an ACE inhibitor or ARB within the last 3 months
5.Patients who have provided written consent

Key exclusion criteria

1.Patients with type 1 diabetes mellitus
2.Patients with cardiovascular disease and with the following conditions
Patients who have undergone coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the last 3 months, patients with unstable angina, patients with a history of myocardial infarction, patients with a history of a transient ischemic attack (TIA) within the last 6 months, patients that are NYHA functional class III or IV or with heart failure, and patients with a history of cerebral infarction within the last 3 months
3. serum Cr>2.5mg/dL or eGFR<30mL/min
4.Patients with severe liver dysfunction
5.Patients with secondary hypertension caused by factors other than diabetes mellitus
6.HbA1c > 9%
7.Patients with pregnancy or nursing
8.Other patients deemed ineligible by an investigator

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Saito

Organization

Fukuoka University Faculty of Medicine

Division name

Division of Nephrology and Rheumatology, Department of Internal Medicine

Zip code


Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan

TEL

+81-92-801-1011

Email

tsaito@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoru Ogahara

Organization

Fukuoka University Faculty of Medicine

Division name

Division of Nephrology and Rheumatology, Department of Internal Medicine

Zip code


Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan

TEL

+81-92-801-1011

Homepage URL


Email

sogahara@cis.fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

The Kidney Foundation, Japan

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2009 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 12 Month 14 Day

Last modified on

2017 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003523


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name